相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The roles of extracellular vesicles in the immune system
Edit I. Buzas
NATURE REVIEWS IMMUNOLOGY (2023)
Extracellular vesicles: Critical players during cell migration
Bong Hwan Sung et al.
DEVELOPMENTAL CELL (2021)
PD-L1 expression as a predictive biomarker for immune checkpoint inhibitors: between a dream and a nightmare
Joseph Zouein et al.
IMMUNOTHERAPY (2021)
TRAPPC4 regulates the intracellular trafficking of PD-L1 and antitumor immunity
Yimeng Ren et al.
NATURE COMMUNICATIONS (2021)
Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies
Kenneth K. W. To et al.
FRONTIERS IN ONCOLOGY (2021)
PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFR
Soma Ghosh et al.
CELL REPORTS (2021)
Microenvironment mapping via Dexter energy transfer on immune cells
Jacob B. Geri et al.
SCIENCE (2020)
Progress and Challenges in Precise Treatment of Tumors With PD-1/PD-L1 Blockade
Youhai Jiang et al.
FRONTIERS IN IMMUNOLOGY (2020)
PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer
Wendan Yu et al.
CELL DEATH & DISEASE (2020)
PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade
Qi Peng et al.
NATURE COMMUNICATIONS (2020)
PD-L1 Reverse Signaling in Dermal Dendritic Cells Promotes Dendritic Cell Migration Required for Skin Immunity
Erin D. Lucas et al.
CELL REPORTS (2020)
PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer
Soyoung A. Oh et al.
NATURE CANCER (2020)
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
J. Mazieres et al.
ANNALS OF ONCOLOGY (2019)
Exploring a Tumor-Intrinsic PD-L1 Signal with Proximity-Dependent Biotin Identification in Lung Cancer Cells
Tiepeng Li et al.
BIOCHEMISTRY (2019)
Mechanisms associated with biogenesis of exosomes in cancer
Kathleen M. McAndrews et al.
MOLECULAR CANCER (2019)
PD-L1 (B7-H1) Competes with the RNA Exosome to Regulate the DNA Damage Response and Can Be Targeted to Sensitize to Radiation or Chemotherapy
Xinyi Tu et al.
MOLECULAR CELL (2019)
Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis
Laura M. Doyle et al.
CELLS (2019)
Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer
Dong Ha Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
HIP1R targets PD-L1 to lysosomal degradation to alter T cell-mediated cytotoxicity
Huanbin Wang et al.
NATURE CHEMICAL BIOLOGY (2019)
Biogenesis and function of ESCRT-dependent extracellular vesicles
Thomas Juan et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2018)
ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 Presentation
James Monypenny et al.
CELL REPORTS (2018)
Checkpoint Inhibitors in Metastatic EGFR-Mutated Non-Small Cell Lung Cancer A Meta-Analysis
Chee Khoon Lee et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
Riccardo Mezzadra et al.
NATURE (2017)
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
Marian L. Burr et al.
NATURE (2017)
Exosome secretion promotes chemotaxis of cancer cells
Bong Hwan Sung et al.
CELL ADHESION & MIGRATION (2017)
PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity
Maria Gato-Canas et al.
CELL REPORTS (2017)
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz et al.
CELL REPORTS (2017)
Regulation of cargo transfer between ESCRT-0 and ESCRT-I complexes by flotillin-1 during endosomal sorting of ubiquitinated cargo
M. Meister et al.
ONCOGENESIS (2017)
PD-L1 Expression Promotes Epithelial to Mesenchymal Transition in Human Esophageal Cancer
Lujun Chen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
An Approach to Spatiotemporally Resolve Protein Interaction Networks in Living Cells
Braden T. Lobingier et al.
CELL (2017)
Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapy
Panpan Zhang et al.
CANCER SCIENCE (2016)
EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis
Justin F. Gainor et al.
CLINICAL CANCER RESEARCH (2016)
PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
Junzo Hamanishi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2016)
Spatially resolved proteomic mapping in living cells with the engineered peroxidase APEX2
Victoria Hung et al.
NATURE PROTOCOLS (2016)
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
Chia-Wei Li et al.
NATURE COMMUNICATIONS (2016)
Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma The Lung Cancer Mutation Consortium Experience
Lynette M. Sholl et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
PD-L1 Blockade for Cancer Treatment: MEDI4736
Ramy Ibrahim et al.
SEMINARS IN ONCOLOGY (2015)
Identification and Characterization of MEDI4736, an Antagonistic Anti-PD-L1 Monoclonal Antibody
Ross Stewart et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Directed evolution of APEX2 for electron microscopy and proximity labeling
Stephanie S. Lam et al.
NATURE METHODS (2015)
Recruitment of UBPY and ESCRT Exchange Drive HD-PTP-Dependent Sorting of EGFR to the MVB
Nazim Ali et al.
CURRENT BIOLOGY (2013)
Metabolic Alterations in Lung Cancer-Associated Fibroblasts Correlated with Increased Glycolytic Metabolism of the Tumor
Virendra K. Chaudhri et al.
MOLECULAR CANCER RESEARCH (2013)
Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2
Tadashi Yokosuka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Oncogenic mutant forms of EGFR: Lessons in signal transduction and targets for cancer therapy
Gur Pines et al.
FEBS LETTERS (2010)
The Akt kinases Isoform specificity in metabolism and cancer
Eva Gonzalez et al.
CELL CYCLE (2009)
The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins
Camilla Raiborg et al.
NATURE (2009)
Growth Factor-Dependent Trafficking of Cerebellar NMDA Receptors via Protein Kinase B/Akt Phosphorylation of NR2C
Bo-Shiun Chen et al.
NEURON (2009)
Signaling networks assembled by oncogenic EGFR and c-Met
Ailan Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry
Joshua E. Elias et al.
NATURE METHODS (2007)
Clustering class I MHC modulates sensitivity of T cell recognition
David R. Fooksman et al.
JOURNAL OF IMMUNOLOGY (2006)
Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-γ-induced upregulation of B7-H1 (CD274)
SJ Lee et al.
FEBS LETTERS (2006)
Expression of programmed death 1 ligands by murine T cells and APC
T Yamazaki et al.
JOURNAL OF IMMUNOLOGY (2002)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I
DJ Katzmann et al.
CELL (2001)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
